Oscar Ljungholm

Artiklar

Article: SCIENCE ADVANCES. 2021;7(16):eabe6397

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.

Trkulja CL; Jungholm O; Davidson M; Jardemark K; Marcus MM; Hägglund J; Karlsson A; Karlsson R; Bruton J; Ivarsson N; Srinivasa SP; Cavallin A; Svensson P; Jeffries GDM; Christakopoulou M-N; Reymer A; Ashok A; Willman G; Papadia D; Johnsson E; Orwar O
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2021;14:11786469211041368-117864692110413

Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice.

Imbeault S; Gubert Olivé M; Jungholm O; Erhardt S; Wigström H; Engberg G; Jardemark K
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):37

Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls.

Sellgren CM; Gracias J; Jungholm O; Perlis RH; Engberg G; Schwieler L; Landen M; Erhardt S
Article: JOURNAL OF NEUROINFLAMMATION. 2016;13(1):51

Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.

Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S